IL17A and neoplasm: After activating the myeloid differentiation factor 88 (MyD88), the invading commensal bacteria and their products interact with TLRs on tumor-infiltrating myeloid cells, leading to the production of inflammatory cytokines such as IL-23 activating the production of IL-6, IL-22, and IL-17A [91].